Cita APA (7a ed.)

Tamez Pérez, H. E., Delgadillo Esteban, E., Soni Duque, D., Hernández Coria, M. I., & Tamez Peña, A. L. (2017). SGLT2 inhibitors as add on therapy in type 2 diabetes: A real world study.

Cita Chicago Style (17a ed.)

Tamez Pérez, Héctor Eloy, Enrique Delgadillo Esteban, David Soni Duque, Mayra Ivonne Hernández Coria, y Alejandra Lorena Tamez Peña. SGLT2 Inhibitors as Add on Therapy in Type 2 Diabetes: A Real World Study. 2017.

Cita MLA (9a ed.)

Tamez Pérez, Héctor Eloy, et al. SGLT2 Inhibitors as Add on Therapy in Type 2 Diabetes: A Real World Study. 2017.